Clinical Trial Update: Observational Study on the Management of Patients With Non Small Cell Lung Cancer Adenocarcinoma

View source ↗

Summary

This is an observational study update sponsored by AstraZeneca on the management of patients with non-small cell lung cancer (adenocarcinoma), which has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Non Small Cell Lung Cancer | Status: COMPLETED